Elzonris side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Elzonris. Common side effects include capillary leak syndrome among females and capillary leak syndrome among males.
The phase IV clinical study is created by eHealthMe based on 323 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
323 people who take Elzonris and have side effects are studied.
What is Elzonris?
Elzonris has active ingredients of tagraxofusp-erzs. eHealthMe is studying from 241 Elzonris users for its effectiveness, alternative drugs and more.
Number of Elzonris reports submitted per year:
Elzonris side effects by time on the drug *:
Elzonris side effects by gender *:
Elzonris side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Elzonris?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on tagraxofusp-erzs (the active ingredients of Elzonris) and Elzonris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Elzonris:
- Elzonris (241 reports)
All Elzonris side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cardura Xl vs. Amlodipine Besylate; Olmesartan Medoxomil - now
- Zyprexa and Muscle Rigidity - 12 seconds ago
- Zyprexa and Raynaud'S Phenomenon - 15 seconds ago
- Vitamin B12 and Mycelex drug interaction - 20 seconds ago
- Derma-Smoothe/Fs and Nexium drug interaction - 20 seconds ago
- Lexapro and Bile Duct Obstruction - 21 seconds ago
- Salonpas and Ankylosing Spondylitis - 22 seconds ago
- Malarone and Pancreatitis - 43 seconds ago
- Donepezil and Flector drug interaction - 49 seconds ago
- Apriso vs. Methotrexate - 51 seconds ago